Schedule
New Patients Referring Physicians
Find a Doctor
Patient Portal
Log In Enroll
Careers
Locations
1-888-663-3488
English
English Spanish
Donate

Moffitt at ASCO 2025

We are excited to participate in the American Society for Clinical Oncology (ASCO) Annual Meeting from May 30 - June 3.

Moffitt Presentation Schedule

Not Finished Until Cancer Is

Moffitt Cancer Center’s research focuses on cutting edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. At this year’s American Society of Clinical Oncology meeting our faculty will share their innovative research.

The studies our scientists are presenting cover many cancer types and explore cutting edge advances in the areas of immunotherapy, artificial intelligence, radiation therapy, triplet therapy and more.

Stop by our booth #13018 to meet our experts and see the impact Moffitt is making in cancer research. 

Want to learn more about Moffitt?

What information are you interested in?

What is your preferred method of communication?

2025 Featured Articles 

Ozempic Insulin injection pen or insulin cartridge pen for diabetics. Medical equipment for diabetes parients.

GLP-1 Drugs May Lower Risk of Obesity-Related Cancers in People With Diabetes

Study suggests modest protective effect, especially in women

AI Improves Accuracy in Identifying HER2-Low, Ultralow Breast Cancers

Digital training platform improves consistency in HER2 scoring across global study

Connect with Us

Follow Moffitt on X and LinkedIn for live coverage of the Meeting. 

@MoffittNews X(Twitter) 

@Moffitt Cancer Center LinkedIn

Immunotherapy Combo Shows Promise as Pre-Surgical Treatment for Merkel Cell Carcinoma

More than half of patients had no detectable tumor cells after treatment with pembrolizumab and lenvatinib

Study Looks To Improve TIL Therapy for Advanced Melanoma

TIL therapy can be used to treat advanced melanoma when patients do not respond to standard treatment options

graphic image of excess red blood cell and what the blood stream would look like if you had polycythemia vera

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

New Drug Duo Significantly Slows Progression of Aggressive Breast Cancer

Phase 3 trial shows sacituzumab govitecan and pembrolizumab outperform standard treatment in triple-negative breast cancer

Researchers in a lab look over data

Drug Combination Proves More Effective for Patients with Advanced Stage 3 Melanoma

Results of a recent NCI-sponsored clinical trial point to lower disease progression and recurrence rates in patients with melanoma

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

the letters ASCO out front of McCormick Place in Chicago

Is Immunotherapy Before and After Surgery a Better Strategy for Certain Cancers?

Several studies from the ASCO Annual Meeting suggest earlier use of immunotherapy improves survival for colon, head and neck and stomach cancers

Study Shows Combined Therapy Helps Advanced Colorectal Cancer Patients Live Longer

Patients receiving trial medications had a 65.7% partial or complete response to treatment

ASCO Exercise.

Structured Exercise Improves Survival and Quality of Life in Colon Cancer Patients, Study Finds

Three-year international trial shows meaningful gains in disease-free and overall survival following post-treatment physical activity

Explore The ImmunoVerse™

Hosted by Moffitt President and CEO, Dr. Patrick Hwu, The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delves into the intracacies of the body's immune system.

Listen Now

2025 Featured Videos

Plenary - VERIFY Study

graphic image of excess red blood cell and what the blood stream would look like if you had polycythemia vera

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

Oral Sessions

Expert Chats

Posters

Moffitt Perspectives

Moffitt Resources

an abstract graphic

Office of Innovation

The Office of Innovation and Industry Alliances is charged with advancing Moffitt discoveries by forging alliances with industry, licensing technologies, and supporting startups to bring cutting edge

Cell Coast Conference Oct 17-18, 2025

Join us at Hotel Flor in Tampa, FL for an exclusive summit featuring updates on breakthroughs in research and treatment in the cell therapies space.

Moffitt researchers in a lab

Research Careers

Our researchers drive cutting-edge discoveries that are rapidly translated into improved diagnostic, preventive and therapeutic advances.

Cambiar el idioma

Si no encuentra la información que busca o si desea programar una cita, llámenos gratis al 1-888-663-3488.

Gracias.

 

 

 

 

Cancel | Cancelar OK